Next Digital Health (A Wi4 Initiative)

Pearl Secures $58m to Transform Dentistry Practice with Dental AI Pearl, a leading dental AI startup, has secured $58 million in Series B funding to improve patient care. Co-founded in 2019 by Ophir Tanz, Cambron Carter, and Kyle Stanley, the company has received significant capital from the previous financing rounds. Left Lane Capital spearheaded the recently concluded series B funding round with the support of other strategic investors, including Alpha Partners, Smash Capital, and existing investors, Neotribe Ventures, and Craft Ventures. According to the company’s announcement, it will use the new capital to advance innovations in dentistry-focused technologies to improve the health of dental patients globally. Pearl is also looking to expand its portfolio by expanding a new line of dental AI products. Read more: https://lnkd.in/gTNvbXQ7 #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

Essentia Health Unveils New Surgical Robots to Boost Efficiency and Precision in Healthcare A Duluth hospital offering a wide range of healthcare services, Essentia Health has deployed new surgical robots to provide minimally-invasive surgeries quickly, reducing the time patients take under anesthesia as well as recovery, according to a Senior Operations Supervisor for Surgery, Stacy Lund. Fox21 News reported that the company held a “Meet the Robots” last Tuesday and invited the community to interact firsthand with the state-of-the-art equipment. Four different types of robots were on display, and surgeons asked questions about the AI-powered medical procedure assistants. Read more: https://lnkd.in/gscbrR32 #HealthcareNews #healthcareinnovation #HealthcareTechnology #Ai #medicaldevice #RoboticsInHealth #SurgicalRobots #nextdigitalhealth #vineetagrawal #Wi4

RxDiet Secures $3m Seed Funding to Improve Healthcare Outcomes Using AI-driven Food Plans A New York-based health tech company leveraging the power of AI to create medically formulated food plans, RxDiet, has raised $3 million in seed funding to address poor diet, the leading cause of many chronic conditions. Co-founded by Roman Kalista, MD, and Jan Škvařil, the company has received significant support in the seed round to expand its grocery network, strengthen its team, and extend services to diverse payers. The round was spearheaded by Giant Ventures, with contributions from other investors such as FORM Life and Better Ventures, alongside many angel investors including Immad Akhund from Mercury Bank. Read more: https://lnkd.in/gGx9Hg6R #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

Loyal Secures $33.5M Series B financing to Accelerate Product Development and Market Expansion Loyal Health, a health tech company leveraging artificial intelligence to transform its operation through digital patient engagement, has secured $33.5M Series B financing to expand its customer base, accelerate product development, and support customer success. Founded in 2015 by Chad Mallory, the company has received significant investments throughout its previous financing rounds. The latest round received contributions from existing investors such as Concord Health Partners and other strategic investors. According to the company’s announcement, Saurabh Sinha, founder of Emids Technologies, has been appointed to head the Loyal Board of Directors, a position previously held by Chad Mallory before transitioning to the Senior Advisor role. Mark Hipp has also joined the Loyal Board as part of the latest financing deal, bringing his extensive experience and expertise in advising and guiding technology-backed businesses. Read more: https://lnkd.in/gbXU8YF2 #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

Novocuff Raises $26 Million in Series A Funding Round to Reduce Preterm Births Using a Novel Technology Novocuff, Inc., a medical device technology company focused on improving pregnancy outcomes and minimizing the risk of preterm birth, has secured a $26 million series A funding round to fuel growth and support its pivotal clinical trials in the US. The round was spearheaded by AXA Investment Managers via Global Healthcare Private Equity Strategy, supported by a significant investment from Laerdal Million Lives Fund. The round also featured remarkable participation from existing and new investors, such as RH Capital, Laborie, March of Dimes, and Avestria Ventures. Co-founded in 2021 by Amelia Degenkolb and Donald Lee, the company has received significant financial support since its launch with $2 million capital. As part of the investment deal, Curt LaBelle, currently heading Healthcare Private Equity at AXA IM Alts, Vice President of Global Health Investing at AXA IM Alts Lilly deSouza Burr, and Becca Shmukler, from the Laerdal Million Lives Fund, joined the Board chaired by Shacey Petrovic. Read more: https://lnkd.in/giQPQYjT #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #MedicalTechnology #MedicalDevice #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

Novel Blood Filtration Technology Offers Hope for Treatment of Pancreatic Cancer A medical technology company focused on developing and commercializing extracorporeal blood filtration devices, ExThera Medical, has made a groundbreaking breakthrough in treating advanced pancreatic cancer. ExThera Medical announced on Thursday, July 18, that researchers had successfully deployed Seraph® 100 blood filtration media, a novel cancer treatment technology designed to remove Circulating Tumor Cells (CTCs) from pancreatic cancer patients’ bloodstreams. Peter Kuhn, PhD, the study’s lead researcher, co-authors, and the CEO of ExThera Medica, Erin Borger, affirmed that the novel blood filtration device presents an immense opportunity to improve the care of pancreatic cancer patients and has potential application in treating other types of cancer. Read more: https://lnkd.in/gU5WuWni #HealthcareNews #healthcareinnovation #HealthcareTechnology #PancreaticCancer #Ai #medicaldevice #nextdigitalhealth #vineetagrawal #Wi4

CytoReason Secures $80M Series C Funding to Scale AI Disease Models CytoReason, a biotechnology company leveraging computational disease models to help biopharma companies make informed decisions through a data-driven approach, has raised $80 million in a series C funding round to scale its AI-powered disease models. According to the company’s announcement, the new funding will also accelerate growth, increase clinical and molecular data, expand the application of innovative models, strengthen the company's market position, and establish its hub in Cambridge, Massachusetts. Co-founded in 2016 by David H. and Shai Shen-Orr, CytoReason has received significant support from diverse investors, propping its total amount raised and market valuation. In the recently concluded Series C funding round, the company received substantial investments from OurCrowd, Pfizer, NVIDIA, and Thermo Fisher Scientific. Read more: https://lnkd.in/gGyi__Dp #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #AIdiseasemodels #nextdigitalhealth #Wi4 #vineetagrawal

Truvian Health Secures $74M to Extend Comprehensive Blood Testing to Everyone A medical technology company, Truvian Health (“Truvian”), has raised $74 million in a series D funding round to extend access to blood testing to everyone across the globe using its novel platform. Since its founding in 2015 by Dena Marrinucci, Kim Kamdar, and Bala Manian, the company has received significant financial support from diverse investors throughout its development stages. According to the company’s announcement, the latest stage was co-led by Great Point Partners and Wittington Ventures, with a significant contribution from existing investors, including Medical Excellence Capital, LLC, DNS Capital, Tao Capital, 7wireVentures, and TYH Capital. Read more: https://lnkd.in/d9dTs5uC #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

Loci Orthopaedics Raises €12.8 million (13.9M) to Advance Novel Orthopaedic System to Market A medical device startup developing novel technologies to solve unresolved challenges in orthopaedic care, Loci Orthopaedics has secured €12.8 million ($13.9 million) in an oversubscribed Series A round. As announced by the company, the latest capital will be used to augment its initial clinical investigation for regulatory approval and advance its InDx Implant System to clinical validation and commercialization. Co-founded in 2017 by Dr. Brendan Boland and Gerry Clarke, the company received significant investments in its initial funding rounds. The latest round was spearheaded by Seroba, with support from other investors, including Johnson & Johnson Innovation JJDC Inc, Inc., and the European Innovation Council applicant support. Read more: https://lnkd.in/gkxGT8_8 #fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #MedicalDevice #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

A Milestone in Oncology: New AI Diagnostic System Identifies 13 Cancers with 98% Accuracy Researchers have unveiled a new AI system that can detect 13 cancers from tissue samples with 98% accuracy. According to a news report by The Indian Express, Researchers from the University of Cambridge achieved the ground-breaking feat by developing binary and multiclass machine learning models. These models were then used to identify several types of cancers from non-cancerous tissue samples. Read more: https://lnkd.in/gzdGu5BC #HealthcareNews #healthcareinnovation #HealthcareTechnology #Ai #medicalTechnology #5CNetwork #KalyanKalyan Sivasailam #nextdigitalhealth #vineetagrawal #Wi4